• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮中脯氨酰羟化酶结构域蛋白2的缺失增加了周细胞覆盖并促进肺动脉重塑。

Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.

作者信息

Wang Shuo, Zeng Heng, Xie Xue-Jiao, Tao Yong-Kang, He Xiaochen, Roman Richard J, Aschner Judy L, Chen Jian-Xiong

机构信息

Department of Pharmacology and Toxicology, University of Mississippi Medical Center, School of Medicine, Jackson, MS, USA.

School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

出版信息

Oncotarget. 2016 Sep 13;7(37):58848-58861. doi: 10.18632/oncotarget.11585.

DOI:10.18632/oncotarget.11585
PMID:27613846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5312280/
Abstract

Pulmonary arterial hypertension (PAH) is a leading cause of heart failure. Although pulmonary endothelial dysfunction plays a crucial role in the progression of the PAH, the underlying mechanisms are poorly understood. The HIF-α hydroxylase system is a key player in the regulation of vascular remodeling. Knockout of HIF-2α has been reported to cause pulmonary hypertension. The present study examined the role of endothelial cell specific prolyl hydroxylase-2 (PHD2) in the development of PAH and pulmonary vascular remodeling. The PHD2f/f mouse was crossbred with VE-Cadherin-Cre promoter mouse to generate an endothelial specific PHD2 knockout (Cdh5-Cre-PHD2ECKO) mouse. Pulmonary arterial pressure and the size of the right ventricle was significantly elevated in the PHD2ECKO mice relative to the PHD2f/f controls. Knockout of PHD2 in EC was associated with vascular remodeling, as evidenced by an increase in pulmonary arterial media to lumen ratio and number of muscularized arterioles. The pericyte coverage and vascular smooth muscle cells were also significantly increased in the PA. The increase in vascular pericytes was associated with elevated expression of fibroblast specific protein-1 (FSP-1). Moreover, perivascular interstitial fibrosis of pulmonary arteries was significantly increased in the PHD2ECKO mice. Mechanistically, knockout of PHD2 in EC increased the expression of Notch3 and transforming growth factor (TGF-β) in the lung tissue. We conclude that the expression of PHD2 in endothelial cells plays a critical role in preventing pulmonary arterial remodeling in mice. Increased Notch3/TGF-β signaling and excessive pericyte coverage may be contributing to the development of PAH following deletion of endothelial PHD2.

摘要

肺动脉高压(PAH)是心力衰竭的主要原因。尽管肺内皮功能障碍在PAH的进展中起关键作用,但其潜在机制仍知之甚少。HIF-α羟化酶系统是血管重塑调节中的关键参与者。据报道,敲除HIF-2α会导致肺动脉高压。本研究探讨了内皮细胞特异性脯氨酰羟化酶-2(PHD2)在PAH发生发展及肺血管重塑中的作用。将PHD2f/f小鼠与VE-钙黏蛋白-Cre启动子小鼠杂交,以产生内皮特异性PHD2敲除(Cdh5-Cre-PHD2ECKO)小鼠。与PHD2f/f对照相比,PHD2ECKO小鼠的肺动脉压和右心室大小显著升高。内皮细胞中敲除PHD2与血管重塑有关,肺动脉中膜与管腔比值增加以及肌化小动脉数量增加证明了这一点。肺中周细胞覆盖和血管平滑肌细胞也显著增加。血管周细胞的增加与成纤维细胞特异性蛋白-1(FSP-1)表达升高有关。此外,PHD2ECKO小鼠肺动脉的血管周围间质纤维化显著增加。机制上,内皮细胞中敲除PHD2会增加肺组织中Notch3和转化生长因子(TGF-β)的表达。我们得出结论,内皮细胞中PHD2的表达在预防小鼠肺动脉重塑中起关键作用。Notch3/TGF-β信号增加和周细胞过度覆盖可能是内皮PHD2缺失后PAH发生发展的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/2c0b7f1ed4b1/oncotarget-07-58848-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/c29e51fd42f3/oncotarget-07-58848-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/aa2e35b70fdd/oncotarget-07-58848-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/369be33235a5/oncotarget-07-58848-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/489ee5aefbbd/oncotarget-07-58848-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/9444fc1fe54b/oncotarget-07-58848-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/2c0b7f1ed4b1/oncotarget-07-58848-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/c29e51fd42f3/oncotarget-07-58848-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/aa2e35b70fdd/oncotarget-07-58848-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/369be33235a5/oncotarget-07-58848-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/489ee5aefbbd/oncotarget-07-58848-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/9444fc1fe54b/oncotarget-07-58848-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8578/5312280/2c0b7f1ed4b1/oncotarget-07-58848-g006.jpg

相似文献

1
Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.血管内皮中脯氨酰羟化酶结构域蛋白2的缺失增加了周细胞覆盖并促进肺动脉重塑。
Oncotarget. 2016 Sep 13;7(37):58848-58861. doi: 10.18632/oncotarget.11585.
2
Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice.内皮脯氨酰羟化酶结构域蛋白-2缺失促进小鼠肾血管重塑和纤维化
J Cell Mol Med. 2017 Sep;21(9):1967-1978. doi: 10.1111/jcmm.13117. Epub 2017 Mar 7.
3
Endothelial Cell-Specific Prolyl Hydroxylase-2 Deficiency Augments Angiotensin II-Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice.内皮细胞特异性脯氨酰羟化酶-2 缺乏增强了血管紧张素 II 诱导的小鼠动脉僵硬和心脏周细胞募集。
J Am Heart Assoc. 2024 Aug 20;13(16):e035769. doi: 10.1161/JAHA.124.035769. Epub 2024 Jul 26.
4
Regulatory Role of Endothelial PHD2 in the Hepatic Steatosis.内皮细胞PHD2在肝脂肪变性中的调节作用
Cell Physiol Biochem. 2018;48(3):1003-1011. doi: 10.1159/000491968. Epub 2018 Jul 23.
5
Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.内皮细胞和造血细胞中脯氨酰-4-羟化酶2(PHD2)缺乏通过缺氧诱导因子-2α在小鼠和人类中引发闭塞性血管重塑和严重肺动脉高压。
Circulation. 2016 Jun 14;133(24):2447-58. doi: 10.1161/CIRCULATIONAHA.116.021494. Epub 2016 Apr 25.
6
Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.内皮细胞 HIF-2α 通过内皮细胞向间充质转化导致严重肺动脉高压。
Am J Physiol Lung Cell Mol Physiol. 2018 Feb 1;314(2):L256-L275. doi: 10.1152/ajplung.00096.2017. Epub 2017 Oct 26.
7
PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.PHD2 缺失在内皮或动脉平滑肌细胞中揭示了肺动脉高压和纤维化中的血管细胞类型特异性反应。
Angiogenesis. 2022 May;25(2):259-274. doi: 10.1007/s10456-021-09828-z. Epub 2022 Jan 8.
8
The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.内皮脯氨酰-4-羟化酶结构域2/缺氧诱导因子2轴调节小鼠肺动脉压力。
Mol Cell Biol. 2016 May 2;36(10):1584-94. doi: 10.1128/MCB.01055-15. Print 2016 May 15.
9
LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways.脂多糖通过破坏Sirt3/血管生成素/Tie-2和HIF-2α/Notch3信号通路导致周细胞丢失和微血管功能障碍。
Sci Rep. 2016 Feb 12;6:20931. doi: 10.1038/srep20931.
10
miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation.miR-17/20 通过调控脯氨酰羟化酶 2(PHD2)/低氧诱导因子 1(HIF1)来调节肺动脉平滑肌细胞增殖。
J Am Heart Assoc. 2016 Dec 5;5(12):e004510. doi: 10.1161/JAHA.116.004510.

引用本文的文献

1
Oxidative Stress and Inflammation in Hypoxemic Respiratory Diseases and Their Comorbidities: Molecular Insights and Diagnostic Advances in Chronic Obstructive Pulmonary Disease and Sleep Apnea.低氧性呼吸系统疾病及其合并症中的氧化应激与炎症:慢性阻塞性肺疾病和睡眠呼吸暂停的分子见解与诊断进展
Antioxidants (Basel). 2025 Jul 8;14(7):839. doi: 10.3390/antiox14070839.
2
Unraveling the role of HIF and epigenetic regulation in pulmonary arterial hypertension: implications for clinical research and its therapeutic approach.解析缺氧诱导因子(HIF)和表观遗传调控在肺动脉高压中的作用:对临床研究及其治疗方法的启示
Front Med (Lausanne). 2024 Oct 10;11:1460376. doi: 10.3389/fmed.2024.1460376. eCollection 2024.
3

本文引用的文献

1
Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.内皮细胞和造血细胞中脯氨酰-4-羟化酶2(PHD2)缺乏通过缺氧诱导因子-2α在小鼠和人类中引发闭塞性血管重塑和严重肺动脉高压。
Circulation. 2016 Jun 14;133(24):2447-58. doi: 10.1161/CIRCULATIONAHA.116.021494. Epub 2016 Apr 25.
2
LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways.脂多糖通过破坏Sirt3/血管生成素/Tie-2和HIF-2α/Notch3信号通路导致周细胞丢失和微血管功能障碍。
Sci Rep. 2016 Feb 12;6:20931. doi: 10.1038/srep20931.
3
Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review).
糖酵解调节:改善肺动脉高压的新治疗策略(综述)。
Int J Mol Med. 2024 Dec;54(6). doi: 10.3892/ijmm.2024.5439. Epub 2024 Oct 18.
4
Endothelial Cell-Specific Prolyl Hydroxylase-2 Deficiency Augments Angiotensin II-Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice.内皮细胞特异性脯氨酰羟化酶-2 缺乏增强了血管紧张素 II 诱导的小鼠动脉僵硬和心脏周细胞募集。
J Am Heart Assoc. 2024 Aug 20;13(16):e035769. doi: 10.1161/JAHA.124.035769. Epub 2024 Jul 26.
5
A Novel Animal Model for Pulmonary Hypertension: Lung Endothelial-Specific Deletion of in Mice.一种用于肺动脉高压的新型动物模型:小鼠肺内皮特异性缺失 。 (注:原文中“in Mice”前似乎缺失了某个基因相关内容)
J Respir Biol Transl Med. 2024 Jun;1(2). doi: 10.35534/jrbtm.2024.10007. Epub 2024 May 30.
6
Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside.肺动脉高压中的内皮功能:从实验台到病床边
J Clin Med. 2024 Apr 22;13(8):2444. doi: 10.3390/jcm13082444.
7
PHD1-3 oxygen sensors in vivo-lessons learned from gene deletions.体内的PHD1-3氧传感器——从基因缺失中获得的经验教训
Pflugers Arch. 2024 Sep;476(9):1307-1337. doi: 10.1007/s00424-024-02944-x. Epub 2024 Mar 21.
8
Endothelial specific prolyl hydroxylase domain-containing protein 2 deficiency attenuates aging-related obesity and exercise intolerance.内皮细胞特异性脯氨酰羟化酶结构域蛋白 2 缺乏可减轻与衰老相关的肥胖和运动不耐受。
Geroscience. 2024 Aug;46(4):3945-3956. doi: 10.1007/s11357-024-01108-0. Epub 2024 Mar 11.
9
A hypothesis: Potential contributions of metals to the pathogenesis of pulmonary artery hypertension.假说:金属元素对肺动脉高压发病机制的潜在贡献。
Life Sci. 2024 Jan 1;336:122289. doi: 10.1016/j.lfs.2023.122289. Epub 2023 Nov 24.
10
The Emerging Therapeutic Role of Prostaglandin E2 Signaling in Pulmonary Hypertension.前列腺素E2信号通路在肺动脉高压中的新兴治疗作用
Metabolites. 2023 Nov 16;13(11):1152. doi: 10.3390/metabo13111152.
HIF hydroxylase pathways in cardiovascular physiology and medicine.
心血管生理学与医学中的低氧诱导因子羟化酶途径。
Circ Res. 2015 Jun 19;117(1):65-79. doi: 10.1161/CIRCRESAHA.117.305109.
4
Human high-altitude adaptation: forward genetics meets the HIF pathway.人类对高海拔的适应:正向遗传学与缺氧诱导因子(HIF)通路的交汇
Genes Dev. 2014 Oct 15;28(20):2189-204. doi: 10.1101/gad.250167.114.
5
A genetic mechanism for Tibetan high-altitude adaptation.藏族人适应高海拔环境的遗传机制。
Nat Genet. 2014 Sep;46(9):951-6. doi: 10.1038/ng.3067. Epub 2014 Aug 17.
6
Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing.有缺陷的藏族PHD2与p23的结合将高海拔适应与改变的氧感应联系起来。
J Biol Chem. 2014 May 23;289(21):14656-65. doi: 10.1074/jbc.M113.541227. Epub 2014 Apr 7.
7
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.内皮细胞衍生的成纤维细胞生长因子-2 和白细胞介素-6 介导的周细胞覆盖增加是肺动脉高压中平滑肌样细胞的来源。
Circulation. 2014 Apr 15;129(15):1586-97. doi: 10.1161/CIRCULATIONAHA.113.007469. Epub 2014 Jan 30.
8
Notch3 establishes brain vascular integrity by regulating pericyte number.Notch3 通过调节周细胞数量来维持脑血管完整性。
Development. 2014 Jan;141(2):307-17. doi: 10.1242/dev.096107. Epub 2013 Dec 4.
9
Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation.红细胞增多症和肺动脉高压在人类 HIF2A 获得性功能突变的小鼠模型中。
J Biol Chem. 2013 Jun 14;288(24):17134-44. doi: 10.1074/jbc.M112.444059. Epub 2013 May 2.
10
Focus on cardiac pericytes.关注心脏周细胞。
Pflugers Arch. 2013 Jun;465(6):779-87. doi: 10.1007/s00424-013-1240-1. Epub 2013 Feb 27.